Amgen (AMGN)
(Delayed Data from NSDQ)
$330.92 USD
-4.69 (-1.40%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $321.81 -9.11 (-2.75%) 7:16 PM ET
3-Hold of 5 3
C Value C Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (80 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.19 | 1.38 | 9.99 |
Current Quarter Estimate | 5.13 | 3.11 | 61.00 |
Year Ago Quarter Estimate | 4.96 | -4.81 | 54.84 |
Next Quarter Estimate | 5.41 | 3.91 | 63.00 |
Next Year Estimate | 20.53 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.50 | 17.30 | 15.67 |
Next Year | 5.34 | 10.10 | 11.34 |
Last 5 Years | 6.00 | 0.90 | 8.10 |
Next 5 Years | 5.80 | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 18.04 | -6.90 |
Price/Book (MRQ) | 30.39 | 2.05 |
Price/Cash Flow (MRFY) | 12.73 | 16.44 |
Dividend Yield | 2.68% | 0.00% |
Net Profit Margin (TTM) | 10.12% | -154.18% |
Return on Equity (TTM) | 161.72% | -61.34% |
Debt to Equity (MRQ) | 9.64 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.